TR200103473T2 - Kristalli azabisiklo (2.2.2) oktan-3-amin sitratin polimorfları ve farmasötik kompozisyonları. - Google Patents

Kristalli azabisiklo (2.2.2) oktan-3-amin sitratin polimorfları ve farmasötik kompozisyonları.

Info

Publication number
TR200103473T2
TR200103473T2 TR2001/03473T TR200103473T TR200103473T2 TR 200103473 T2 TR200103473 T2 TR 200103473T2 TR 2001/03473 T TR2001/03473 T TR 2001/03473T TR 200103473 T TR200103473 T TR 200103473T TR 200103473 T2 TR200103473 T2 TR 200103473T2
Authority
TR
Turkey
Prior art keywords
octane
amine
citratin
polymorphs
pharmaceutical compositions
Prior art date
Application number
TR2001/03473T
Other languages
English (en)
Inventor
James Castaldi Michael
Joseph Quallich George
Theophilus Wint Lewin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200103473T2 publication Critical patent/TR200103473T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Tek bir kristalli poliformik form (2S,3S)-N(metoksi-5-t-butilfenil-metil-2- difenilmetil-1-azobisiklo (2.2.2) oktan-3-amin sitrat(sitrat monohidrat) ve bunun farmasötik kompozisyonu.Sitrat monohidratin polimorfik formunun farmasötik kompozisyonu, emez tedavi amaçli formülasyon için avantajli bir kararliliga sahiptir. Bu farmasötik kompozisyonun verilmesi, aninda birakmali oral dozaj formu, tercihen tablet veya kapsül ile veya venöz içinedir.
TR2001/03473T 1999-06-01 2000-05-18 Kristalli azabisiklo (2.2.2) oktan-3-amin sitratin polimorfları ve farmasötik kompozisyonları. TR200103473T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
TR200103473T2 true TR200103473T2 (tr) 2002-04-22

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03473T TR200103473T2 (tr) 1999-06-01 2000-05-18 Kristalli azabisiklo (2.2.2) oktan-3-amin sitratin polimorfları ve farmasötik kompozisyonları.

Country Status (48)

Country Link
US (1) US6255320B1 (tr)
EP (1) EP1181290B1 (tr)
JP (1) JP3830816B2 (tr)
KR (1) KR100476606B1 (tr)
CN (1) CN1146565C (tr)
AP (1) AP2001002349A0 (tr)
AR (1) AR033331A1 (tr)
AT (1) ATE244239T1 (tr)
AU (1) AU767334B2 (tr)
BG (1) BG65240B1 (tr)
BR (1) BR0011094A (tr)
CA (1) CA2372238C (tr)
CO (1) CO5170463A1 (tr)
CY (1) CY2007011I1 (tr)
CZ (1) CZ295819B6 (tr)
DE (1) DE60003679T2 (tr)
DK (1) DK1181290T3 (tr)
DZ (1) DZ3050A1 (tr)
EA (1) EA003731B1 (tr)
EC (1) ECSP003508A (tr)
EE (1) EE200100656A (tr)
ES (1) ES2199825T3 (tr)
GT (1) GT200000087A (tr)
HN (1) HN2000000077A (tr)
HR (1) HRP20010904A2 (tr)
HU (1) HUP0201301A3 (tr)
IL (1) IL146406A0 (tr)
MA (1) MA26742A1 (tr)
MX (1) MXPA01012325A (tr)
MY (1) MY133508A (tr)
NO (1) NO20015848L (tr)
NZ (1) NZ515349A (tr)
OA (1) OA11956A (tr)
PA (1) PA8496101A1 (tr)
PE (1) PE20010209A1 (tr)
PL (1) PL196046B1 (tr)
PT (1) PT1181290E (tr)
SI (1) SI1181290T1 (tr)
SK (1) SK285820B6 (tr)
SV (1) SV2001000093A (tr)
TN (1) TNSN00120A1 (tr)
TR (1) TR200103473T2 (tr)
TW (1) TWI285204B (tr)
UA (1) UA66925C2 (tr)
UY (1) UY26176A1 (tr)
WO (1) WO2000073304A1 (tr)
YU (1) YU81101A (tr)
ZA (1) ZA200109775B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0507301A (pt) * 2004-01-30 2007-06-26 Pfizer Prod Inc composições farmacêuticas de antagonistas do receptor de nuerocinina e ciclodextrina e métodos para melhor toleráncia no local de injeção
MXPA06007964A (es) * 2004-01-30 2007-01-26 Pfizer Prod Inc Antagonistas del receptor nk-1 para mejorar la recuperacion de anestesia.
JP5021318B2 (ja) * 2004-01-30 2012-09-05 ファイザー・プロダクツ・インク β−シクロデキストリンを液体投薬形態に用いて多用量製剤を達成するための抗菌性防腐剤
KR100812046B1 (ko) * 2004-02-02 2008-03-10 화이자 프로덕츠 인크. 1-(2ｓ,3ｓ)-2-벤즈히드릴-ｎ-(5-삼급-부틸-2-메톡시벤질)퀴누클리딘-3-아민의 제조 방법
SG11201507286QA (en) * 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN112979639B (zh) * 2019-12-16 2025-08-08 凯默斯医药科技(上海)有限公司 一种马罗皮坦新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27776C2 (uk) * 1991-05-31 2000-10-16 Пфайзер Інк. Похідні хінуклідину та їх фармацевтично прийнятні солі, що є антагоністами речовини р у ссавців, фармацевтична композиція, що має антагоністичну дію на речовину р у ссавців
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
PL196046B1 (pl) 2007-11-30
EP1181290B1 (en) 2003-07-02
JP2003501354A (ja) 2003-01-14
ATE244239T1 (de) 2003-07-15
IL146406A0 (en) 2002-07-25
CZ20014269A3 (cs) 2002-04-17
TWI285204B (en) 2007-08-11
DE60003679T2 (de) 2004-05-27
EA200101108A1 (ru) 2002-04-25
BR0011094A (pt) 2002-03-19
CY2007011I2 (el) 2010-07-28
DZ3050A1 (fr) 2004-03-27
PA8496101A1 (es) 2002-07-30
SK17332001A3 (sk) 2002-07-02
HUP0201301A3 (en) 2002-10-28
UY26176A1 (es) 2000-12-29
HK1046284A1 (en) 2003-01-03
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
DE60003679D1 (de) 2003-08-07
CN1146565C (zh) 2004-04-21
AU767334B2 (en) 2003-11-06
SK285820B6 (sk) 2007-09-06
EE200100656A (et) 2003-02-17
ES2199825T3 (es) 2004-03-01
WO2000073304A1 (en) 2000-12-07
SV2001000093A (es) 2001-11-08
PT1181290E (pt) 2003-09-30
AR033331A1 (es) 2003-12-17
CN1353711A (zh) 2002-06-12
OA11956A (en) 2006-04-13
NO20015848D0 (no) 2001-11-30
DK1181290T3 (da) 2003-09-29
ECSP003508A (es) 2002-02-25
MY133508A (en) 2007-11-30
KR20020010688A (ko) 2002-02-04
CA2372238C (en) 2006-12-19
CY2007011I1 (el) 2010-07-28
HRP20010904A2 (en) 2003-02-28
HUP0201301A2 (en) 2002-08-28
NZ515349A (en) 2004-03-26
YU81101A (sh) 2004-07-15
HN2000000077A (es) 2001-02-02
KR100476606B1 (ko) 2005-03-18
CA2372238A1 (en) 2000-12-07
CZ295819B6 (cs) 2005-11-16
BG106204A (en) 2002-07-31
PL352716A1 (en) 2003-09-08
JP3830816B2 (ja) 2006-10-11
TNSN00120A1 (fr) 2005-11-10
MXPA01012325A (es) 2002-07-22
MA26742A1 (fr) 2004-12-20
AU4424800A (en) 2000-12-18
SI1181290T1 (en) 2003-12-31
GT200000087A (es) 2001-11-22
EP1181290A1 (en) 2002-02-27
UA66925C2 (uk) 2004-06-15
AP2001002349A0 (en) 2001-12-31
PE20010209A1 (es) 2001-03-01
EA003731B1 (ru) 2003-08-28
BG65240B1 (bg) 2007-09-28
ZA200109775B (en) 2002-11-28
CO5170463A1 (es) 2002-06-27

Similar Documents

Publication Publication Date Title
DE60142891D1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
AR035320A1 (es) Compuestos activadores de hppardelta, composicion farmaceutica, su uso en la preparacion de medicamentos, metodo para el tratamiento de enfermedades mediadas por hppardelta
SE8804629D0 (sv) New therapeutically active compounds
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
UA85359C2 (ru) Таблетка, содержащая гранулированный материал с kmd-3213
DE60313359D1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
TR199900336T2 (tr) EAA antagonistleri olarak tetrahidrokinolin türevleri.
NO894616D0 (no) Fremgangsmaate for fremstilling av anti-aterosklerotisk aktive diarylforbindelser.
ATE268174T1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
FI891865A0 (fi) Laekemedel som innehaoller azelastin med kontrollerad frigoering av det verksamma aemnet.
TR200103473T2 (tr) Kristalli azabisiklo (2.2.2) oktan-3-amin sitratin polimorfları ve farmasötik kompozisyonları.
IL92799A0 (en) Benzimidazole derivatives with gastric acid inhibition and process for its preparation
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
TW200517127A (en) Novel composition
SE9901572D0 (sv) New compounds
NO950177D0 (no) Farmakologisk aktive erivater
ATE302010T1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
ES2170168T3 (es) Composiciones recubiertas entericamente de derivados de 1,5-benzodiacepina con actividad antagonista o agonista de cck.
MD940244A (ro) Derivaţi noi ai tetrazolului, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor